Patient versus physician preferences for lipid‐lowering drug therapy: A discrete choice experiment by Lingli Zhang, Jiali Chen, Zhaoliu Cao, Mengdie Zhang, Rui Ma, Pei Zhang, Guiqing Yao, Xin Li

Subjects: Get full text

PCSK9: A New Target for Lipid-Lowering Therapy by Nutjaree Jeenduang

Subjects: Get full text

Lipid-lowering drug targets associated with risk of respiratory disease: a Mendelian randomization study by Zhipeng Gong, Dongsheng Wu, Yin Ku, Congyao Zou, Lin Qiu, Xiaohu Hao, Lunxu Liu

Subjects: “…Lipid-lowering drug target…”
Get full text

Genetic association of lipids and lipid lowering drug target genes with sarcoidosis by Wei Tan, Zicheng Liang, Yu Liu, Xiaoning Tan, Guangbo Tan

Subjects: Get full text

Mechanisms underlying direct actions of hyperlipidemia on myocardium: an updated review by Yu Si Yao, Tu Di Li, Zhi Huan Zeng

Subjects: Get full text

Effect of lipid-lowering medications in patients with coronary artery bypass grafting surgery outcomes by Chunxia Shi, Zugui Zhang, Jordan Goldhammer, David Li, Bob Kiaii, Victor Rudriguez, Douglas Boyd, David Lubarsky, Richard Applegate, Hong Liu

Subjects: Get full text

Lipid-lowering drug targets and lung related diseases: a Mendelian randomization study by Haifeng Yu, Xiaofei Zhang, Bian Wen, Shuo Hu, Bin Ni

Subjects: “…lipid-lowering drug…”
Get full text

Association Between Genetically Proxied Lipid-Lowering Drug Targets and Renal Cell Carcinoma: A Mendelian Randomization Study by Luyang Liu, Chao Sheng, Zhangyan Lyu, Hongji Dai, Kexin Chen

Subjects: “…lipid-lowering drug…”
Get full text

Lipid changes due to fenofibrate treatment are not associated with changes in DNA methylation patterns in the GOLDN study by Mithun eDas, Ryan eIrvin, Jin eSha, Stella eAslibekyan, Bertha eHidalgo, Rodney T Perry, Degui eZhi, Hemant K Tiwari, Devin eAbsher, Jose M Ordovas, Donna K Arnett

Subjects: Get full text

Lipid-lowering drugs affect lung cancer risk via sphingolipid metabolism: a drug-target Mendelian randomization study by Honglin Li, Lei Zhang, Feiran Yang, Xiaoteng Feng, Rong Fu, Ruohan Zhao, Xiurong Li, Huijie Li

Subjects: “…lipid-lowering drug…”
Get full text

Causal Relationships between Lipid-Lowering Drug Target and Aortic Disease and Calcific Aortic Valve Stenosis: A Two-Sample Mendelian Randomization by Liang Yang, Mingyuan Xu, Xixi Gao, Jingwen Liu, Dingkai Zhang, Zhaohua Zhang, Zhidong Ye, Jianyan Wen, Peng Liu

Subjects: Get full text

Lipid-lowering drugs and inflammatory bowel disease’s risk: a drug-target Mendelian randomization study by Jiaxi Zhao, Rong Chen, Mengqi Luo, Hongping Gong, Kaixin Li, Qian Zhao

Subjects: Get full text

Associations Between Gene Variants of Lipid‐Lowering Drug Targets and Adverse Outcomes After Ischemic Stroke by Lulu Sun, Qilu Zhang, Mengyao Shi, Yang Liu, Zhengbao Zhu, Jing Zhang, Hao Peng, Aili Wang, Jing Chen, Tan Xu, Yonghong Zhang, Jiang He

Subjects: Get full text

Interdependent Impact of Lipoprotein Receptors and Lipid-Lowering Drugs on HCV Infectivity by Francisco J. Zapatero-Belinchón, Rina Ötjengerdes, Julie Sheldon, Benjamin Schulte, Belén Carriquí-Madroñal, Graham Brogden, Laura M. Arroyo-Fernández, Florian W. R. Vondran, Benjamin Maasoumy, Thomas von Hahn, Gisa Gerold

Subjects: Get full text

Genetic association analysis of lipid-lowering drug target genes in chronic kidney disease by Yi Zhang, Yi Zhang, Guangyang Ou, Lei Peng, Jian Pan, Shaohua Zhang, Jianguo Shi

Subjects: Get full text

Management of blood lipids in post-kidney transplant patients: a systematic review and network meta-analysis by Bohan Luo, Bohan Luo, Shan Zhong, Xiaoxiao Wang, Pu Guo, Yifu Hou, Wenjia Di

Subjects: Get full text

New reimbursement criteria for lipid-lowering drugs by Mario Eandi

Subjects: “…lipid-lowering drugs…”
Get full text

Trends in drug prescriptions for type 2 diabetes, hypertension, and dyslipidemia among adults with non-alcoholic fatty liver disease by Toshiya Machida, Taku Obara, Makoto Miyazaki, Jun Inoue, Nariyasu Mano

Subjects: Get full text

Effects of dietary inulin, statin, and their co-treatment on hyperlipidemia, hepatic steatosis and changes in drug-metabolizing enzymes in rats fed a high-fat and high-sucrose diet by Sugatani Junko, Sadamitsu Satoshi, Wada Tadashi, Yamazaki Yasuhiro, Ikari Akira, Miwa Masao

Subjects: Get full text

Association of lipid-lowering drugs with COVID-19 outcomes from a Mendelian randomization study by Wuqing Huang, Jun Xiao, Jianguang Ji, Liangwan Chen

Subjects: “…lipid-lowering drugs…”
Get full text